Mostrar el registro sencillo de la publicación

dc.contributor.authorRojas, Armando
dc.contributor.authorMorales, Miguel
dc.contributor.authorGonzález-Bonet, Ileana
dc.contributor.authorAraya, Paulina
dc.date.accessioned2019-05-14T13:38:01Z
dc.date.available2019-05-14T13:38:01Z
dc.date.issued2019
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/2086
dc.description.abstractThe Receptor for Advanced Glycation End Products (RAGE) is an important cell surface receptor, which belongs to the IgG super family and is now considered as a pattern recognition receptor. Because of its relevance in many human clinical settings, it is now pursued as a very attractive therapeutic target. However, particular features of this receptor such as a wide repertoire of ligands with different binding domains, the existence of many RAGE variants as well as the presence of cytoplasmatic adaptors leading a diverse signaling, are important limitations in the search for successful pharmacological approaches to inhibit RAGE signaling. Therefore, the present review aimed to display the most promising approaches to inhibit RAGE signaling, and provide an up to date review of progress in this area.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceCurrent Drug Targets, 20(3), 340-346es_CL
dc.subjectAdvanced glycation end productses_CL
dc.subjectCytoplasmatic adaptorses_CL
dc.subjectInhibitorses_CL
dc.subjectIntracellular signalinges_CL
dc.titleInhibition of RAGE Axis signaling: A pharmacological challengees_CL
dc.typeArticlees_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.uriwww.eurekaselect.com/164756/articlees_CL
dc.ucm.doidoi.org/10.2174/1389450119666180820105956es_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile